Literature DB >> 24314851

Negative symptoms, past and present: a historical perspective and moving to DSM-5.

Dolores Malaspina1, Julie Walsh-Messinger2, Wolfgang Gaebel3, Lianne Morris Smith4, Alyson Gorun4, Vasthie Prudent5, Daniel Antonius6, Fabien Trémeau7.   

Abstract

The diagnosis of schizophrenia includes "positive" and "negative" symptoms. These titles were developed to respectively reflect if the symptoms are additions to normal experiences, such as delusions and hallucinations, or if they refer to the absence or the loss of normal emotional function or behavior. This paper describes the history of the negative symptom concept, from its origins up to the considerations for the DSM-5, including the steps that produced the current conceptualizations. The DSM-5 only includes deficits in emotional expression and avolition as negative symptoms, which can be assessed from interview information. Factor analyses show they encompass most other negative symptom items. In addition to using these negative symptoms in a categorical manner to make a diagnosis, the DSM-5 has quantitative severity ratings of the negative symptoms, along with ratings of delusions, cognitive symptoms, motor symptoms, disorganization, depression and mania. With this approach, the different symptom domains, including negative symptoms, can be measured and tracked over time. Another change in the DSM-5 is the dropping of the schizophrenia subtypes that have been included in earlier volumes, as they were not useful in treatment decisions or prognosis. An intended outcome of these changes in DSM-5 is for clinicians to directly treat the individual psychopathological domains of the disorder for optimizing individual outcomes. Finally, this paper includes descriptions of the negative symptom items from over a dozen different scales.
© 2013 Published by Elsevier B.V. and ECNP.

Entities:  

Keywords:  Avolition; Diagnosis; Emotional expression; Historical; Negative symptoms; Schizophrenia

Mesh:

Year:  2013        PMID: 24314851     DOI: 10.1016/j.euroneuro.2013.10.018

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  8 in total

1.  Prefrontal neuronal integrity predicts symptoms and cognition in schizophrenia and is sensitive to genetic heterogeneity.

Authors:  Dolores Malaspina; Thorsten M Kranz; Adriana Heguy; Sheila Harroch; Robert Mazgaj; Karen Rothman; Adam Berns; Sumya Hasan; Daniel Antonius; Raymond Goetz; Mariana Lazar; Moses V Chao; Oded Gonen
Journal:  Schizophr Res       Date:  2016-02-28       Impact factor: 4.939

2.  Metabolic Abnormalities in the Hippocampus of Patients with Schizophrenia: A 3D Multivoxel MR Spectroscopic Imaging Study at 3T.

Authors:  E J Meyer; I I Kirov; A Tal; M S Davitz; J S Babb; M Lazar; D Malaspina; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-21       Impact factor: 3.825

3.  Confirmatory Factor Analysis and Differential Relationships of the Two Subdomains of Negative Symptoms in Chronically Ill Psychotic Patients.

Authors:  Annemarie P M Stiekema; Edith J Liemburg; Lisette van der Meer; Stynke Castelein; Roy Stewart; Jaap van Weeghel; André Aleman; Richard Bruggeman
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

Review 4.  Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia.

Authors:  Tanja Veselinović; Irene Neuner
Journal:  CNS Drugs       Date:  2022-07-13       Impact factor: 6.497

5.  Hyperschematia after right brain damage: a meaningful entity?

Authors:  Gilles Rode; Roberta Ronchi; Patrice Revol; Yves Rossetti; Sophie Jacquin-Courtois; Irene Rossi; Giuseppe Vallar
Journal:  Front Hum Neurosci       Date:  2014-01-28       Impact factor: 3.169

6.  Are negative symptoms in schizophrenia a distinct therapeutic target?

Authors:  Octavia Oana Capatina; Ioana Valentina Miclutia
Journal:  Clujul Med       Date:  2018-01-15

Review 7.  Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment.

Authors:  Christoph U Correll; Nina R Schooler
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-21       Impact factor: 2.570

8.  Spanish validation of the self-evaluation of negative symptoms scale SNS in an adolescent population.

Authors:  Juan F Rodríguez-Testal; Salvador Perona-Garcelán; Sonia Dollfus; María Valdés-Díaz; Jesús García-Martínez; Miguel Ruíz-Veguilla; Cristina Senín-Calderón
Journal:  BMC Psychiatry       Date:  2019-10-29       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.